Guggenheim Starts Aclaris Therapeutis (ACRS) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: ACRS) | Delayed: 3.68 -0.06 (1.6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.74 | 52 Week High | $33.88 | |||
| Open | $3.81 | 52 Week Low | $14.12 | |||
| Day High | $3.88 | P/E | N/A | |||
| Day Low | $3.63 | EPS | $0.00 | |||
| Volume | 2,045,279 | |||||
